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Abstract
Background: The effect of early organ dysfunction on long-term survival in acute pancreatitis (AP)
patients is unknown.
Objective: The aim of this study was to ascertain whether early organ dysfunction impacts on long-term
survival after an episode of AP.
Methods: A retrospective analysis was performed using survival data sourced from a prospectively
maintained database of patients with AP admitted to the Royal Infirmary of Edinburgh during a 5-year
period commencing January 2000. A multiple organ dysfunction syndrome (MODS) score of ≥ 2 during
the first week of admission was used to define early organ dysfunction. After accounting for in-hospital
deaths, long-term survival probabilities were estimated using the Kaplan–Meier test. The prognostic
significance of patient characteristics was assessed by univariate and multivariate analyses using Cox's
proportional hazards methods.
Results: A total of 694 patients were studied (median follow-up: 8.8 years). Patients with early organ
dysfunction (MODS group) were found to have died prematurely [mean survival: 10.0 years, 95%
confidence interval (CI) 9.4–10.6 years] in comparison with the non-MODS group (mean survival: 11.6
years, 95% CI 11.2–11.9 years) (log-rank test, P = 0.001) after the exclusion of in-hospital deaths.
Multivariate analysis confirmed MODS as an independent predictor of long-term survival [hazard ratio
(HR): 1.528, 95% CI 1.72–2.176; P = 0.019] along with age (HR: 1.062; P < 0.001), alcohol-related
aetiology (HR: 2.027; P = 0.001) and idiopathic aetiology (HR: 1.548; P = 0.048).
Conclusions: Early organ dysfunction in AP is an independent predictor of long-term survival even when
in-hospital deaths are accounted for. Negative predictors also include age, and idiopathic and alcohol-
related aetiologies.
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Introduction
Acute pancreatitis (AP) is a common disease characterized by
acute inflammation of the pancreas, usually triggered by the
passage of gallstones or excessive alcohol consumption.1,2 Usually
an episode of AP will resolve with supportive measures, but the
disease may also be fatal and results in reported mortality of 6–9%
in the UK.3–6
Many systems have been devised to stratify the subgroup of
patients who present with, or are predicted to develop, the severe
form of AP, but these systems focus on the severity of the index
episode. According to the widely accepted and updated definition
of severe acute pancreatitis (SAP),7 which incorporates evidence
of persistent organ failure, approximately one in four patients
with AP will experience a severe episode.5,8,9 Unsurprisingly, mor-
tality rates in SAP are considerably higher than inmild disease and
range from 14% to 30%.5,10,11 It is well established that the major-
ity of deaths occur early in the disease course; up to 60% of all AP
deaths occur during the first 7 days of hospital admission and are
mostly attributable to deteriorating organ function.3,4,6,12–14 It is
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understandable, therefore, that clinical research in AP to date has
largely focused on improving early outcomes; relatively little is
known about late deaths amongst hospital survivors.
Few contemporary studies have investigated long-term survival
and the relevant prognostic factors in AP.15,16 Long-term studies
have for the most part examined morbidity outcomes, such as
progression to chronic pancreatitis, or have focused upon a severe
pancreatitis subgroup. Those that do report survival suggest that
SAP hospital survivors may carry a reduced life expectancy.17 After
the exclusion of inpatient mortality, death rates amongst AP
patients are reported to be in the order of one death in every four
to eight cases, over 5–8 years.17,18 Late deaths seem to be most
commonly attributed to cardiovascular disease or malignancy,15,16
but the factors that reduce long-term survival are likely to be
complex.
The aim of this study was to determine whether early acute
organ dysfunction is associated with altered long-term survival in
hospital survivors of AP.
Materials and methods
Study approval
Caldicott Guardian approval was obtained to allow the use of
confidential patient data. The study was assessed by the University
of Edinburgh/National Health Service (NHS) Lothian ACCORD
Research and Development Office and the South East Scotland
Research Ethics Service and was declared exempt from require-
ments for formal research ethics committee review as a clinical
audit.
Data collection and inclusion criteria
In 2013, a retrospective analysis was performed using long-term
survival data sourced from a prospectively maintained database of
patients with AP admitted to the Royal Infirmary of Edinburgh
during the 5-year period between January 2000 and December
2004. This historical cohort was originally identified from the
Lothian Surgical Audit database,19 and its clinical details and
immediate outcomes have been previously reported.20 For this
cohort, existing data on age, gender, organ dysfunction, aetiology
of pancreatitis, necrosectomy and disease severity were sup-
plemented with survival data. Patients for whom data on these
characteristics were unavailable were excluded from subsequent
analysis. For those patients with recurrent attacks of AP, the ear-
liest episode during the study period was taken as the index
episode for the purposes of survival analysis.
Patient inclusion in the original patient cohort was based on the
presence of clinical features compatible with AP, supported by
the finding of elevated serum amylase (three times higher than the
upper limit of the laboratory reference range). In instances in
which a strong clinical suspicion of AP in the context of a non-
diagnostic amylase result existed, radiological evidence of AP by
means of computed tomography or the finding of pancreatitis at
laparotomy was required for inclusion. Patients admitted with
chronic pancreatitis were excluded.
Definitions: severity, aetiology and organ dysfunction
Severity stratification was performed in accordance with the origi-
nal version of the Atlanta consensus definition,21 which was the
classification system in use at the time when patients in the study
cohort presented with AP. Patients were not retrospectively reclas-
sified according to the revised 2012 Atlanta criteria7 in order to
avoid introducing error. Patients with an admission APACHE II
(Acute Physiology and Chronic Health Evaluation) score of ≥ 8
were classified as predicted severe.
Gallstones were considered to be the precipitating cause of pan-
creatitis when gallbladder or bile duct calculi were detected by any
imaging procedure. In the absence of gallstones and when exces-
sive consumption of alcohol was reported by the patient or the
patient’s family, the pancreatitis was classified as alcohol-induced.
When no definite cause was identified, the disease was character-
ized as idiopathic. Rarer established causes were collated under the
category ‘other’.
Organ dysfunction scores were calculated for all patients at
24 h, 48 h and 7 days, based on the most extreme laboratory
values or clinical measurements during each 24-h period, for five
(respiratory, cardiovascular, renal, haematological, central
nervous system) of six organ systems that constitute the multiple
organ dysfunction score (MODS).22 Hepatic dysfunction (serum
bilirubin) was excluded in order to avoid the confounding effects
of biliary obstruction. A MODS score of ≥ 2 (based on dysfunc-
tion of a single or more than one organ system) at one or more
time-points was considered to define organ dysfunction. The
duration and persistence of organ dysfunction could not be retro-
spectively ascertained from the existing database; attempts to
retrieve archived primary records to gather these data were not
successful.
Follow-up and mortality
In-hospital mortality, overall mortality and long-term survival
were the main outcome measures of the present study. NHS
Lothian electronic patient records were individually reviewed; for
surviving patients, the date of the most recent general practitioner
and/or hospital visit, outpatient clinic attendance or hospital dis-
charge were defined as the point of last known contact. Dates of
death were retrieved and recorded for non-survivors.
Statistical analysis
Data for continuous variables are presented as the mean ± stand-
ard deviation (SD) or as the median and interquartile range
(IQR). Categorical variables are presented as absolute and relative
frequencies. Comparisons between groups were performed using
Student’s t-test, the Mann–Whitney U-test, the Kolmogorov–
Smirnov test and the chi-squared test, as appropriate.
The Kaplan–Meier method was used to estimate survival prob-
abilities. The generalized Wilcoxon test was used to detect early
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death rate differences between groups and the log-rank test was
applied to detect differences manifesting throughout the entire
follow-up period. Survival times were calculated from the date of
admission to the date of death from any cause or date of last
contact in survivors. Patients lost from follow-up were censored at
the date of confirmed last contact. The prognostic impact of
patient characteristics on survival was assessed by univariate and
multivariate Cox’s proportional hazards regression. For univariate
analyses, the proportional hazards assumption was examined
graphically with the use of pairwise Cox log(-log) plots, revealing
approximately parallel curves between groups for each of the cat-
egorical covariates MODS, gender, severity and aetiology. Linear
regression was implemented to test for goodness-of-fit of
Schoenfeld partial residuals23 against natural logarithmic survival
times for each of the aforementioned covariates; no violation of
the proportional hazards assumption was revealed. The linearity
assumption for age was confirmed graphically by examining the
respective Cox log(-log) plots, after transformation to a categori-
cal variable with six strata. Similar procedures were used for mul-
tivariate analyses.
Selection of variables for the multivariate Cox regression model
was performed in accordance with the ‘purposeful selection’ algo-
rithm,24,25 originally described by Hosmer and Lemeshow.26 Vari-
ables with a univariate P-value of > 0.25 were originally selected as
candidates for multivariate analysis. Covariates were subsequently
removed from the model if they were found to be non-significant
at the α = 0.1 level and not to be confounders. Confounding was
defined as a change of > 15% in any of the remaining covariate
estimates. Variables that were not selected for the original model
were returned one at a time, and any that were significant at the
α = 0.15 level were retained.24 This procedure resulted in a multi-
variate model containing age, MODS, gender, severity and aetiol-
ogy. The necrosectomy variable did not satisfy the proportional
hazards assumption and was examined with the use of stratified
Cox regression.
Results of the Cox models are presented as hazard ratios (HRs)
with 95% confidence intervals (95% CIs) together with the
P-values from Wald’s tests. All statistical tests were based on a
two-sided α-value of 0.05. Statistical analysis was performed using
IBM spss Statistics Version 19.0 (IBM Corp., Armonk, NY, USA).
Figures were designed using GraphPad Prism Version 6.0
(GraphPad Software, Inc., La Jolla, CA, USA). This double-arm
cohort study followed the principles of the STROBE (strengthen-
ing the reporting of observational studies in epidemiology)
statement.27
Results
Demographics
Unique patient identifiers with corresponding survival data and
variables of interest were available for 694 of 759 (91.4%) AP
patients in the database and were included in the present study.
With regard to classification of disease severity according to
APACHE II scores, 256 (36.9%) patients were predicted to have a
severe attack, although ultimately 268 (38.6%) suffered from
some degree of organ dysfunction during the first week of admis-
sion. A total of 235 (33.9%) patients had a MODS score of ≥ 2 at
one or more time-points during the first week of their hospital
stay and were classified as having organ dysfunction (denoted as
the ‘MODS group’). Sixty-nine (9.9%) patients underwent one or
more necrosectomy procedures during the study interval. These
were performed predominantly as open procedures because mini-
mally invasive retroperitoneal pancreatic (MIRP) necrosectomy
was not routinely performed in the department during the study
period. Patients’ demographic characteristics are summarized in
Table 1.
Study follow-up
The median follow-up in the whole patient series was 8.8 years.
After excluding in-hospital deaths, median follow-up was 9.0
years. This period was marginally comparable between the MODS
group (8.7 years, IQR: 4.7–10.5 years) and non-MODS group (9.1
years, IQR: 6.6–10.6 years) after the exclusion of in-hospital
deaths (Mann–Whitney U-test, P = 0.046; Kolmogorov–Smirnov
test, P = 0.105).
Overall survival
There were 36 (5.2%) in-hospital deaths in total, 35 of which
occurred during the first 2.2 months. During the follow-up
period, 179 patients died, giving an overall mortality rate of 31.0%
(215 of 694 patients). Median survival in the overall patient
sample remained undefined because more than 50% of patients
were still alive at the end of follow-up. The overall mean survival
was 10.6 years (95% CI 10.2–10.9 years); after the exclusion of
in-hospital deaths this increased to 11.1 years (95% CI 10.8–11.5
years).
Organ failure and survival
Analysis of the overall patient sample demonstrated a clear
difference in survival between the MODS and non-MODS
groups (Fig. 1). Mean survival in the MODS group (8.6 years,
95% CI 7.9–9.3 years) was significantly lower than that in the
non-MODS group (11.5 years, 95% CI 11.1–11.9 years)
(Wilcoxon test, P < 0.001; log-rank test, P < 0.001). The highest
frequency of death occurred during the in-hospital period; the
majority of these patients had a MODS score of ≥ 2. Four
(11.1%) of the 36 patients who died as inpatients had a MODS
score of < 2.
To investigate long-term mortality, inpatient deaths were
removed from the analysis. Interestingly and importantly, with
this exclusion, mean survival in MODS group hospital survivors
(10.0 years, 95% CI 9.4–10.6 years) remained significantly lower
than that in non-MODS group hospital survivors (11.6 years, 95%
CI 11.2–11.9 years) (Wilcoxon test, P = 0.002; log-rank test,
P = 0.001). Furthermore, the survival curves continued to diverge
several years after the index episode of AP (Fig. 2). Again, median
HPB 791
HPB 2014, 16, 789–796 © 2014 International Hepato-Pancreato-Biliary Association
survival was not defined; however the 75th percentiles of survival
were 6.5 years and 9.9 years in theMODS and non-MODS groups,
respectively. Survival rates in each group at 1, 3, 5 and 10 years are
shown in Table 2.
To account for the difference in mean ± SD age between the
MODS (59.9 ± 17.1 years) and non-MODS (54.3 ± 17.9 years)
groups (P < 0.001), and because other AP characteristics may
impact on long-term survival, a multivariate analysis was per-
Table 1 Demographic characteristics of patients with acute pancreatitis
Characteristics Overall sample Non-MODS
groupa
MODS groupa In-hospital
deaths
Survivorsa Non-survivorsa
Sample size, n (%) 694 (100%) 455 (69.1%) 203 (30.9%) 36 (5.2%) 479 (72.8%) 179 (27.2%)
Age, years, median (IQR) 57.1 (43.2–71.2) 54.3 (40.3–69.3) 59.9 (47.7–74.0) 70.9 (79.9–57.4) 52.1 (39.0–65.0) 66.7 (79.5–54.2)
Gender, n (%)
Male 355 (51.2%) 228 (50.1%) 106 (52.2%) 21 (58.3%) 236 (49.3%) 98 (54.7%)
Female 339 (48.8%) 227 (49.9%) 97 (47.8%) 15 (41.7%) 243 (50.7%) 81 (45.3%)
Aetiology of pancreatitis, n (%)
Gallstones 337 (48.6%) 223 (49.0%) 104 (51.2%) 10 (27.8%) 237 (49.5%) 90 (50.3%)
Alcohol 223 (32.1%) 159 (34.9%) 54 (26.6%) 10 (27.8%) 158 (33.0%) 55 (30.7%)
Idiopathic 92 (13.3%) 54 (11.9%) 27 (13.3%) 11 (30.6%) 54(11.3%) 27 (15.1%)
Other 42 (6.1%) 19 (4.2%) 18 (8.9%) 5 (13.9%) 30 (6.3%) 7 (3.9%)
Severity, n (%)
Mild 438 (63.1%) 380 (83.5%) 56 (27.6%) 2 (5.6%) 338 (70.6%) 98 (54.7%)
Severe 256 (36.9%) 75 (16.5%) 147 (72.4%) 34 (94.4%) 141 (29.4%) 81 (45.3%)
Necrosectomy, n (%) 69 (9.9%) 17 (3.7%) 42 (20.7%) 10 (27.8%) 43 (9.0%) 16 (8.9%)
In-hospital deaths, n (%) 36 (5.2%) N/A N/A N/A N/A N/A
Post-discharge deaths, n (%) 179 (25.8%) 107 (59.8%) 72 (40.2%) N/A N/A 179 (100%)
MODS, n (%) 235 (33.9%) N/A N/A 32 (88.9%) 131 (27.3%) 72 (40.2%)
aAfter exclusion of in-hospital deaths.
MODS, multiple organ dysfunction syndrome; IQR, interquartile range; N/A, not available.
Figure 1 Kaplan–Meier survival plot by group of patients (non-MODS group, n = 459; MODS group, n = 235), representing cumulative
percentages of surviving patients by time in years. A distinct, steep decrease is evident on the MODS curve during the first months of the
study, corresponding to in-hospital deaths. A clear difference in survival is observed between the two groups. Vertical tick-marks represent
right-censored patients. MODS, multiple organ dysfunction syndrome
792 HPB
HPB 2014, 16, 789–796 © 2014 International Hepato-Pancreato-Biliary Association
formed. The MODS score was shown to be an independent pre-
dictor of patient survival, with the MODS group carrying a higher
level of risk for post-discharge death than the non-MODS group
in both univariate and multivariate analyses. Age and cause of
pancreatitis were also established as individual predictors, whereas
severity and gender were identified as confounding factors
(Table 3). When necrosectomy was added by stratification on the
multivariate Cox regression model, a negligible effect was
observed. Specifically, the resulting HR for the MODS group was
1.573 (95% CI 1.102–2.246; P = 0.013).
A supplementary univariate Cox regression analysis was per-
formed in the MODS group alone (after the exclusion of
in-hospital deaths) in order to examine whether the magnitude
of the MODS score (worst MODS score value of days 1, 2 and 7 of
admission) or APACHE II score on the day of admission had any
effect on long-termsurvival.No significant effectswere revealed for
either theMODS score (HR: 0.876,95%CI 0.748–1.026;P = 0.102)
or APACHE II score (HR: 1.019, 95% CI 0.954–1.088; P = 0.573).
Discussion
This study demonstrates that organ dysfunction has a lasting
negative impact on long-term survival after an attack of AP.
Importantly, this effect is seen after the exclusion of in-hospital
deaths and is independent of age, aetiology and gender. In addi-
tion, age and an alcohol-related or idiopathic aetiology were also
found to negatively influence long-term survival.
The extent to which the consequences of critical illness contrib-
ute to post-discharge mortality is poorly understood,28–31 espe-
cially in AP. No previous study has specifically investigated the
impact of early organ dysfunction as a predictive marker for long-
term mortality. Findings of the available long-term AP studies
have been equivocal in associating multiple organ failure or
various surrogate markers of organ dysfunction with long-term
survival. Lund et al.32 found that an increased Ranson’s score and
length of stay in the intensive care department were associated
with an increased long-term incidence of mortality in univariate
Figure 2 Kaplan–Meier survival plot by group of patients, after the exclusion of in-hospital deaths (non-MODS group, n = 455; MODS group,
n = 203), representing the percentages of surviving patients by time in years. A clear, moderately increasing difference in survival is observed
between the two groups. Vertical tick-marks represent right-censored patients. MODS, multiple organ dysfunction syndrome
Table 2 Number of patients at risk and survival rates for each group at 1, 3, 5 and 10 years of follow-up, after exclusion of in-hospital deaths
Follow-up MODS group Non-MODS group
Patients
at risk
Cumulative proportion
of patients surviving
Standard
error
Patients
at risk
Cumulative proportion
of patients surviving
Standard
error
1 year 181 0.92 0.02 429 0.97 0.01
3 years 163 0.85 0.03 404 0.91 0.01
5 years 151 0.79 0.03 370 0.86 0.02
10 years 63 0.55 0.04 152 0.72 0.02
MODS, multiple organ dysfunction syndrome.
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but not multivariate analyses. Conversely, Halonen et al.17
reported that a smaller proportion of late-death patients had suf-
fered multiple organ failure than had long-term survivors. There
was no statistical analysis of this frequency as the study had other
objectives pertaining to quality of life outcomes, but this is a
surprising result and is difficult to rationalize. However, median
follow-up in this study was limited to 61 months, the rate of
capture of events (deaths) was subsequently low and the number
of participants relatively small.17 Furthermore, acute organ dys-
function has been shown to be associated with reduced life expec-
tancy amongst survivors of critical illness compared with matched
controls in a number of other conditions.33,34
In addition to early organ dysfunction, increasing age was
observed to be an independent predictor of reduced survival. It is
important not to dismiss this finding as obvious, albeit expected,
because the observation refers to more than just the fact that older
people die sooner from all causes. Although age has been estab-
lished as an independent predictor in the present and previous
studies,35–37 it has been suggested that poorer outcomes in elderly
patients may reflect residual functional disability and dysfunction
of organ systems caused by critical illness.38 This may be sup-
ported by the findings of Lankisch et al., who reported that the
most common causes of death were cardiovascular and cerebro-
vascular diseases.16 This finding was echoed by Nøjgaard et al.
with reference to cardiovascular disease.39 The pathophysiological
mechanisms and exact long-term confounding effects of critical
illness on individual patient subgroups, particularly elderly
patients, deserve further investigation.
It is known that the aetiology of AP can influence morbidity
amongst hospital survivors, but the influence of aetiology on
long-termmortality has been less well researched. Compared with
biliary pancreatitis, alcohol seems to have greater deleterious
effects in AP with regard to exocrine insufficiency and morpho-
logical changes to the pancreas16 and thus it may be unsurprising
that patients with alcohol-related pancreatitis have a life expec-
tancy lower than that reported for gallstone pancreatitis. Nøjgaard
et al.39 reported significantly higher long-term mortality in
patients with AP related to high alcohol consumption, in keeping
with the results of the present study.
The longitudinal design of the present study, its long follow-up
with a median of approximately 9 years, and the fact that it was
conducted in a single centre and included consecutive AP patients
regardless of disease severity or treatment are amongst its
strengths. Potential weaknesses include the study’s retrospective
design, although a prospective long-term survival study of this
duration would be a major undertaking. Secondly, there is little
information regarding the mode of death or any subsequent
comorbidity of survivors. The latter detail would certainly merit
further investigation. Furthermore, it was not feasible to retrieve
and include in the analysis data on the comorbid status of the
present cohort. It is therefore possible, and indeed one might
argue reasonable, that patients with comorbidities may have been
at higher risk for organ dysfunction during AP, which as a conse-
quence resulted in shorter survival. Future studies would benefit
from including details on important confounders such as detailed
patient comorbid status, the presence of pancreatic necrosis,
occurrence of pancreatic insufficiency and other long-term
sequelae, as well as specific organ system dysfunction duration
and severity. Notwithstanding these weaknesses, the present study
identifies an interesting and important long-term negative impact
Table 3 Association of patient characteristics with overall survival, after exclusion of in-hospital deaths
Factors Overall survival
Univariate analyses Multivariate analysis
Crude HR 95% CI P-value Adjusted HR 95% CI P-value
MODS
Yes 1.661 1.232–2.240 0.001 1.528 1.072–2.176 0.019
No 1 1
Gender
Male 1.181 0.879–1.585 0.269 1.302 0.946–1.793 0.106
Female 1 1
Age 1.050 1.040–1.061 < 0.001 1.062 1.049–1.075 < 0.001
Severity
Severe 1.862 1.387–2.499 < 0.001 0.850 0.587–1.231 0.390
Mild 1 1
Cause
Gallstones 1 1
Alcohol 0.927 0.662–1.296 0.656 2.027 1.359–3.024 0.001
Idiopathic 1.350 0.878–2.076 0.171 1.548 1.004–2.387 0.048
Other 0.788 0.365–1.701 0.544 1.488 0.679–3.263 0.321
HR, hazard ratio; 95% CI, 95% confidence interval; MODS, multiple organ dysfunction syndrome.
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of organ dysfunction in AP, which extends beyond the injury seen
in the critical care unit during the index episode. This work
reinforces the importance of the early identification, stratification
and correct management of extrapancreatic organ dysfunction in
AP.
Early organ dysfunction in AP is associated with a shortened
lifespan. It is hypothesized that patients who sustain organ dys-
function during their index episode, and who survive, accrue sys-
temic changes which impact negatively on life expectancy in
comparison with hospital survivors without multiple organ dys-
function. In AP, the effects of critical illness do not cease after the
initial insult has subsided. This study reinforces the cardinal need
to identify and pre-empt organ dysfunction, and introduces the
need to consider interventions that impact on long-term out-
comes in high-risk individuals.
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